AJCC to include Oncotype DX
Starting in 2018, the Eighth Edition of the American Joint Committee on Cancer Staging Manual will be used to stage cancer patients.
At Genomic Health, every person who gets one of our tests is just that: a person first, then a patient.
How much do ineffective cancer treatments cost the healthcare system? In the US alone, Oncotype IQ tests have saved more than $3.5 billion.
The Eighth Edition AJCC Staging Manual will go into effect in 2018, and it will change staging for T1-2 N0 M0 breast cancer patients.
Latest TAILORx Data
After 5 years, 95% of women with a low Oncotype DX Breast Recurrence Score result were recurrence-free with hormone therapy alone.
Sign up for Our Healthcare Professional Updates